TFF3 and dysplasia: Notably, cytosponge-TFF3 testing could offer a feasible, safe, and acceptable screening method for the early diagnosis of treatable dysplasia and early cancer through a patient-swallowed sponge that collects esophageal epithelial cells for analysis.28